Nomura Securities Maintains a 'Buy' on Mindray Medical (MR) After Meeting with CFO

June 5, 2012 8:44 AM EDT Send to a Friend
Nomura Securities maintains a 'Buy' on Mindray Medical (NYSE: MR) price target of $34.00.

Analyst, Gideon Lo, said, "Takeaways ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login